DR. BRENNAN: The next order of business is a four-hour summary by myself and Dr. Borden of the achievements. I think that will take place in written form. The important thing, I think, is to thank everybody who participated, and the second, perhaps most important, thing is that this kind of group's intellectual collaboration not fail.
The major achievement, I think, is the achievements directed at the importance of the biology of these tumors, and the importance of accurate tissue, not only collection but distribution.

We have not yet got to the situation where I think we can formally recommend that patients with this disease be treated solely at specific places, but I think we can at least intellectually agree that a patient in whom the diagnosis has not been made should be well served by considering institutions where appropriate imaging, diagnostic pathology, and treatment is available, That is something that should come out from this website, as patients are our greatest advocates in identifying the fact that the first approach to this disease is often the best.

So, on behalf of Dr. Borden and myself, Dr. Saxman, and all the people who made such an important contribution to this, I would like to thank you for coming. Dr. Saxman has some closing remarks that are logistic in nature, and we will try to put together a summary by myself and Dr. Borden, or Dr. Borden with a little bit of help from me, of what has taken place today. I personally thank you, as do my co-organizers.

DR. SAXMAN: I would also like to take just a moment to have you help me thank Dr. Borden and Dr. Brennan as the co-chairs of this meeting, the organizing team -- or the planning team -- Bob Bell, Murali Sundaram, Paul Meltzer, Jaap Verweij, Chris Fletcher -- and the speakers and breakout group leaders. I think they have done a tremendous job and have done a lot of work. There is a lot of work to follow, so please help me thank them for what has been a very productive meeting.

[Applause.]

TOP